NM_001166114.2:c.181G>C

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2

The NM_001166114.2(PNPLA6):​c.181G>C​(p.Val61Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00224 in 1,582,828 control chromosomes in the GnomAD database, including 82 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. V61V) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.012 ( 41 hom., cov: 32)
Exomes 𝑓: 0.0012 ( 41 hom. )

Consequence

PNPLA6
NM_001166114.2 missense

Scores

17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.0250

Publications

3 publications found
Variant links:
Genes affected
PNPLA6 (HGNC:16268): (patatin like phospholipase domain containing 6) This gene encodes a phospholipase that deacetylates intracellular phosphatidylcholine to produce glycerophosphocholine. It is thought to function in neurite outgrowth and process elongation during neuronal differentiation. The protein is anchored to the cytoplasmic face of the endoplasmic reticulum in both neurons and non-neuronal cells. Mutations in this gene result in autosomal recessive spastic paraplegia, and the protein is the target for neurodegeneration induced by organophosphorus compounds and chemical warfare agents. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009]
PNPLA6 Gene-Disease associations (from GenCC):
  • ataxia-hypogonadism-choroidal dystrophy syndrome
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • PNPLA6-related spastic paraplegia with or without ataxia
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • retinal dystrophy-ataxia-pituitary hormone abnormality-hypogonadism syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hereditary spastic paraplegia 39
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • cerebellar ataxia-hypogonadism syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Laurence-Moon syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • trichomegaly-retina pigmentary degeneration-dwarfism syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

PP2
Missense variant in the PNPLA6 gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 29 curated pathogenic missense variants (we use a threshold of 10). The gene has 7 curated benign missense variants. Gene score misZ: 4.3547 (above the threshold of 3.09). Trascript score misZ: 3.5139 (above the threshold of 3.09). GenCC associations: The gene is linked to retinal dystrophy-ataxia-pituitary hormone abnormality-hypogonadism syndrome, cerebellar ataxia-hypogonadism syndrome, PNPLA6-related spastic paraplegia with or without ataxia, ataxia-hypogonadism-choroidal dystrophy syndrome, trichomegaly-retina pigmentary degeneration-dwarfism syndrome, hereditary spastic paraplegia 39, Laurence-Moon syndrome.
BP4
Computational evidence support a benign effect (MetaRNN=0.0018042326).
BP6
Variant 19-7535969-G-C is Benign according to our data. Variant chr19-7535969-G-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 240703.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0121 (1846/152290) while in subpopulation AFR AF = 0.0428 (1779/41552). AF 95% confidence interval is 0.0412. There are 41 homozygotes in GnomAd4. There are 860 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 41 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PNPLA6NM_001166114.2 linkc.181G>C p.Val61Leu missense_variant Exon 1 of 32 ENST00000600737.6 NP_001159586.1 Q8IY17A0A384DVU0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PNPLA6ENST00000600737.6 linkc.181G>C p.Val61Leu missense_variant Exon 1 of 32 1 NM_001166114.2 ENSP00000473211.1 A0A384DVU0
ENSG00000268614ENST00000601870.1 linkn.*477G>C non_coding_transcript_exon_variant Exon 7 of 10 4 ENSP00000471492.1 M0R0W3
ENSG00000268614ENST00000601870.1 linkn.*477G>C 3_prime_UTR_variant Exon 7 of 10 4 ENSP00000471492.1 M0R0W3

Frequencies

GnomAD3 genomes
AF:
0.0121
AC:
1839
AN:
152172
Hom.:
40
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0427
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00281
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000132
Gnomad OTH
AF:
0.00669
GnomAD2 exomes
AF:
0.00299
AC:
590
AN:
197048
AF XY:
0.00208
show subpopulations
Gnomad AFR exome
AF:
0.0405
Gnomad AMR exome
AF:
0.00210
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000693
Gnomad OTH exome
AF:
0.000992
GnomAD4 exome
AF:
0.00119
AC:
1696
AN:
1430538
Hom.:
41
Cov.:
32
AF XY:
0.00106
AC XY:
749
AN XY:
709466
show subpopulations
African (AFR)
AF:
0.0426
AC:
1420
AN:
33298
American (AMR)
AF:
0.00195
AC:
78
AN:
39956
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25538
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38678
South Asian (SAS)
AF:
0.000157
AC:
13
AN:
82642
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
46346
Middle Eastern (MID)
AF:
0.00266
AC:
15
AN:
5646
European-Non Finnish (NFE)
AF:
0.0000200
AC:
22
AN:
1099112
Other (OTH)
AF:
0.00249
AC:
148
AN:
59322
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
106
211
317
422
528
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0121
AC:
1846
AN:
152290
Hom.:
41
Cov.:
32
AF XY:
0.0116
AC XY:
860
AN XY:
74454
show subpopulations
African (AFR)
AF:
0.0428
AC:
1779
AN:
41552
American (AMR)
AF:
0.00268
AC:
41
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000132
AC:
9
AN:
68018
Other (OTH)
AF:
0.00662
AC:
14
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
90
179
269
358
448
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00410
Hom.:
7
Bravo
AF:
0.0138
ESP6500AA
AF:
0.0449
AC:
197
ESP6500EA
AF:
0.000117
AC:
1
ExAC
AF:
0.00339
AC:
406
Asia WGS
AF:
0.00318
AC:
11
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Oct 02, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Hereditary spastic paraplegia 39 Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Oct 29, 2020
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mucolipidosis type IV Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Laurence-Moon syndrome;C1848745:Trichomegaly-retina pigmentary degeneration-dwarfism syndrome;C1859093:Ataxia-hypogonadism-choroidal dystrophy syndrome;C2677586:Hereditary spastic paraplegia 39 Benign:1
May 13, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary spastic paraplegia Benign:1
Apr 07, 2021
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Spastic Paraplegia, Recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.073
BayesDel_addAF
Benign
-0.73
T
BayesDel_noAF
Benign
-0.79
CADD
Benign
7.9
DANN
Benign
0.71
DEOGEN2
Benign
0.0090
.;T;.;.;.;T;.;.;.;.
Eigen
Benign
-1.1
Eigen_PC
Benign
-0.98
FATHMM_MKL
Benign
0.17
N
LIST_S2
Benign
0.79
.;T;T;T;T;T;T;T;T;T
MetaRNN
Benign
0.0018
T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.92
T
PhyloP100
-0.025
PrimateAI
Benign
0.46
T
PROVEAN
Benign
-0.15
N;.;.;N;.;N;N;.;.;.
REVEL
Benign
0.032
Sift
Benign
1.0
T;.;.;T;.;T;T;.;.;.
Sift4G
Benign
0.65
T;T;T;T;T;T;T;T;T;T
Polyphen
0.0
B;.;.;.;.;.;B;.;.;.
Vest4
0.15
MutPred
0.33
.;.;.;.;.;.;.;.;.;Loss of sheet (P = 0.007);
MVP
0.081
MPC
1.1
ClinPred
0.0021
T
GERP RS
-2.9
PromoterAI
-0.032
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.038
gMVP
0.48
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs112732576; hg19: chr19-7600855; API